In metastatic melanoma, the master regulator of MHC genes, Class II Major Histocompatibility Complex Transactivator (CIITA), was significantly downregulated compared to vertical growth phase melanomas, which was considered to account for the discrepancy between expression level and DNA copy number [10,44,45]. This evidence concerns the gene CIITA and metastatic melanoma.